Genprex Inc reports results for the quarter ended December 31 - Earnings Summary

• Genprex Inc GNPX.OQ reported a quarterly adjusted loss of $1.15​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-3.96. The lone analyst forecast for the quarter was for a loss of 39 cents per share.

• Reported revenue was zero​.

• Genprex Inc's reported EPS for the quarter was a loss of $1.15​.

• The company reported a quarterly loss of $4.61 million.

• Genprex Inc shares had held steady so far this quarter and lost 71.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 35.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Genprex Inc is $7.50

This summary was machine generated from LSEG data April 1 at 12:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)